CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹380 Cr | ₹21 Cr | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹380 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹-55 Cr |
| Mar2023 | ₹-109 Cr |
| Mar2022 | ₹-146 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹380 Cr | 1,706.37 | |
| Mar2025 | ₹21 Cr | Positive | |
| Mar2024 | ₹-55 Cr | Negative | |
| Mar2023 | ₹-109 Cr | Negative | |
| Mar2022 | ₹-146 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,347.4 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
| MANKIND PHARMA | ₹101,632.0 Cr | 3% | 0.8% | 7.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 6% |
1.7% |
-4.4% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses